|
|
||||||||
1 Division of Cardiovascular Medicine and Molecular Cardiobiology, Boyer Center for Molecular Medicine, and 2 Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, 06536-0812; and 3 Section of Pathology, University of Michigan School of Dentistry, Ann Arbor, Michigan, 48109-1078
The ErbB, or
epidermal growth factor receptor (EGF-r), family of transmembrane
tyrosine kinase receptors has been demonstrated to play an important
role in growth regulation and intracellular signaling in a wide variety
of cell types. Targeted deletion of neuregulin (an ErbB ligand) in mice
results in endocardial cushion abnormalities, suggesting that these
receptor-ligand interactions have important effects on vascular
endothelial growth and development. To study the role of ErbB receptor
signaling in vascular endothelium, we investigated the expression
pattern of the various receptor family members and the effect of ErbB
receptor stimulation in human umbilical vein endothelial cells (HUVEC).
We demonstrate that ErbB2 (neu), ErbB3, and ErbB4 are highly expressed,
whereas ErbB1 (EGF-r) is undetectable. Stimulation of HUVEC with
recombinant neuregulin-
(an ErbB3/4 ligand) induces rapid calcium
fluxes, receptor tyrosine phosphorylation, and cell proliferation. We demonstrate marked in vitro and in vivo angiogenic responses to neuregulin-
, which are independent of vascular endothelial cell growth factor. These findings support an important role for the ErbB
family of receptors in endothelial cell signaling and function, including neuregulin-induced angiogenesis.
epidermal growth factor receptor family; vascular biology; human endothelial cells; vascular endothelial cell growth factor; tyrosine kinase receptors
This article has been cited by other articles:
![]() |
L. T. Vaszar, T. Nishimura, J. D. Storey, G. Zhao, D. Qiu, J. L. Faul, R. G. Pearl, and P. N. Kao Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats Physiol Genomics, April 13, 2004; 17(2): 150 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hoffmann, E. Eugene, X. Nassif, P.-O. Couraud, and S. Bourdoulous Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis J. Cell Biol., October 1, 2001; 155(1): 133 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bagheri-Yarmand, R. K. Vadlamudi, R.-A. Wang, J. Mendelsohn, and R. Kumar Vascular Endothelial Growth Factor Up-regulation via p21-activated Kinase-1 Signaling Regulates Heregulin-beta 1-mediated Angiogenesis J. Biol. Chem., December 8, 2000; 275(50): 39451 - 39457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. T. Hii, N. Moghadammi, A. Dunbar, and A. Ferrante Activation of the Phosphatidylinositol 3-Kinase-Akt/Protein Kinase B Signaling Pathway in Arachidonic Acid-stimulated Human Myeloid and Endothelial Cells. INVOLVEMENT OF THE ErbB RECEPTOR FAMILY J. Biol. Chem., July 13, 2001; 276(29): 27246 - 27255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |